Nanalysis Scientific (NSCIF) Financial Statements
Nanalysis Scientific Financial Overview
Nanalysis Scientific's market cap is currently $11.97M. The company's EPS TTM is ―; its P/E ratio is -3.46; Nanalysis Scientific has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 3.97M | $ 11.14M | $ 10.24M | $ 5.17M | $ 6.06M |
| Operating Income | $ -12.95M | $ -9.91M | $ -1.19M | $ -3.63M | $ 58.00K |
| EBITDA | $ -11.85M | $ -5.67M | $ 1.38M | $ -1.86M | $ -554.00K |
| Net Income | $ -16.78M | $ -9.91M | $ -1.77M | $ -3.68M | $ -1.66M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 53.82M | $ 69.90M | $ 37.79M | $ 23.99M | $ 18.31M |
| Total Debt | $ 21.97M | $ 10.75M | $ 5.99M | $ 3.78M | $ 1.51M |
| Net Debt | $ 21.21M | $ 7.23M | $ -4.42M | $ 618.00K | $ -5.11M |
| Total Liabilities | $ 30.34M | $ 22.33M | $ 13.83M | $ 9.64M | $ 3.19M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -15.73M | $ -15.47M | $ -1.20M | $ -623.00K | $ 781.00K |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD
